SCHEMBL7216565

SCHEMBL7216565

CCOc1ccc(COc2ccc3c(c2)C=C(C(=O)Nc2ccc(CN(C)C4CCOCC4)cc2)CCC3)cc1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCR2 P41597 5/20 0.69
CCR5 P51681 13/20 0.49
CXCR3 P49682 3/20 0.49
CCR7 P32248 2/20 0.49
CXCR5 P32302 1/20 0.48
POLB P06746 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
MEN1 O00255 1/20 0.40
ALDH1A1 P00352 1/20 0.40
TP53 P04637 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
GAA P10253 1/20 0.40
MAPT P10636 1/20 0.40
CYP2C19 P33261 1/20 0.40
KMT2A Q03164 1/20 0.40
MCL1 Q07820 1/20 0.40
CACNA1B Q00975 1/20 0.40
APBA1 Q02410 1/20 0.40
SAE1 Q9UBE0 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7215741 0.93 CCR2 (0.70) CCR2CCR5CXCR3CCR7CXCR5
SCHEMBL7222258 0.93 CCR2 (0.80) CCR2CCR5CXCR3CCR7CXCR5
SCHEMBL7222732 0.93 CCR2 (0.70) CCR2CCR5CXCR3CCR7CXCR5
SCHEMBL7216624 0.91 CCR2 (0.74) CCR2CCR5CXCR3CCR7CXCR5
SCHEMBL7222708 0.89 CCR2 (0.67) CCR2CCR5CXCR3CCR7CXCR5
Hydrochloric Acid SCHEMBL7216574 0.87 CCR2 (0.68) CCR2CCR5CXCR3CCR7CXCR5
SCHEMBL7222327 0.87 CCR2 (0.72) CCR2CCR5CXCR3CCR7CXCR5
Hydrochloric Acid SCHEMBL7216952 0.87 CCR2 (0.72) CCR2CCR5CXCR3CCR7CXCR5
Hydrochloric Acid SCHEMBL7223014 0.87 CCR2 (0.65) CCR2CCR5CXCR3CCR7CXCR5
SCHEMBL7218232 0.87 CCR2 (0.65) CCR2CCR5CXCR3CCR7CXCR5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6627651-B1 Exhibiting preventive and therapeutic effects against HIV infectious diseases wherein R1 is an optionally substituted five- or six-membered ring group; X1 is a free valency or the like; W is a divalent group and inhibitors of HIV (human TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2003-09-30 US disclosed
EP-1182195-A1 CYCLIC COMPOUNDS AND USES THEREOF Takeda Chemical Industries, Ltd. (JP) 2002-02-27 EP disclosed